Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results
Rhea-AI Summary
Tenon Medical (NASDAQ:TNON) will release third quarter 2025 financial results for the period ended September 30, 2025 after market close on Thursday, November 13, 2025. The company will host a conference call the same day at 4:30 p.m. Eastern Time to discuss results and hold a Q&A with covering analysts.
Dial-in details: US 1-877-407-0792, Int'l 1-201-689-8263. Webcast available via the TNON conference call link. Audio playback will be available through November 27, 2025 on Tenon’s investor relations site or by telephone replay (1-844-512-2921 US; 1-412-317-6671 Int'l) using access code 13756541.
Positive
- None.
Negative
- None.
News Market Reaction – TNON
On the day this news was published, TNON declined 0.83%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
LOS GATOS, CA / ACCESS Newswire / November 3, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced plans to release financial results for the third quarter 2025 ended September 30, 2025 after market close on Thursday, November 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Thursday, November 13, 2025 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through November 27, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13756541.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which include: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) Augmenting spinal fusion. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, Catamaran Transfixation Fusion Device®, SImmetry® are registered trademarks of Tenon Medical, Inc. MAINSAILTM, and SImmetry+™ are also trademarks of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Tenon Medical (NASDAQ:TNON) release Q3 2025 financial results?
What time is the Tenon (TNON) Q3 2025 conference call on November 13, 2025?
How can investors join the Tenon (TNON) earnings call on November 13, 2025?
Will there be a replay of the Tenon (TNON) Q3 2025 conference call and how long is it available?
What is the telephone replay number and access code for the Tenon (TNON) November 13, 2025 call?
